Aclaris Therapeutics Inc.

NASDAQ: ACRS · Real-Time Price · USD
1.88
0.19 (11.24%)
At close: Aug 15, 2025, 3:59 PM
1.83
-2.40%
After-hours: Aug 15, 2025, 07:57 PM EDT

Aclaris Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-15.43M -15.09M -96.55M -7.59M -10.99M -16.94M -1.49M -29.26M -29.57M -28.16M -27.64M -19.95M -20.53M -18.79M -22.8M -21.15M -18.16M -28.75M
Depreciation & Amortization
114K 128K 143K 221K 242K 243K 228K 219K 218K 198K 190K 193K 206K 208K 197K 191K 247K 288K
Stock-Based Compensation
3.06M 3.54M 2.86M 3M 2.9M 2.09M 1.27M 5.95M 6.52M 6.81M 4.81M 4.19M 3.69M 2.35M 3.85M 3.7M 3.83M 2.67M
Other Working Capital
-1.74M -3.67M 1.95M 25.23M -1.19M -10.86M 13.62M -1.09M 185K -2.03M -6.38M 3.55M 2.79M -1.66M -3.07M 2.28M 315K 120M
Other Non-Cash Items
1.5M 300K 85.61M 758K 200K 2.8M -26.3M 2.33M -1.7M -800K 7.1M 2.2M -3.4M -1.2M 2.2M 900K 4.8M 16.44M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 6.26M -635K 198K n/a n/a n/a n/a n/a n/a 752K n/a n/a
Change in Working Capital
759K -1.94M -994K 25.6M -4.68M -9.01M 13.27M -3.16M 3.67M -4.4M -3.58M 5.55M 368K -3.53M -519K 5M -2.94M -2.88M
Operating Cash Flow
-9.99M -13.06M -8.94M 22M -12.32M -20.82M -6.76M -24.56M -20.65M -26.35M -19.11M -7.82M -19.67M -20.97M -17.07M -10.61M -12.22M -12.23M
Capital Expenditures
-21K -43K -35.81M n/a 14K -135K -441K -84K -231K -553K -105K -150K -186K -164K -200K -56K -52K n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -32.62M 19.43M -26.35M -2.81M -1.37M 21.04M n/a -52K n/a n/a n/a
Purchase of Investments
-19.93M -10M -70.43M -14.34M -35.22M n/a n/a -17.16M -89.99M -28.52M -46.02M -33.63M -70.54M -14.56M -35.29M -52.57M -61.48M -85.81M
Sales Maturities Of Investments
25M 29.99M 17.51M 17.13M 34.53M 16.97M 7.99M 49.78M 70.56M 54.88M 48.83M 35M 49.5M 44.65M 26.32M 14.96M 16.06M 10.5M
Other Investing Acitivies
n/a -833K n/a n/a n/a n/a n/a 32.62M -19.43M 26.35M 2.81M 1.37M -21.04M 30.1M 52K -37.62M -45.42M -75.31M
Investing Cash Flow
5.05M 19.12M -88.72M 2.79M -674K 16.83M 7.55M 32.53M -19.66M 25.8M 2.7M 1.22M -21.22M 29.93M -9.18M -37.67M -45.47M -75.31M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -11.48M n/a n/a
Common Stock Repurchased
n/a -275K -333K -10K -11K -55K n/a n/a n/a n/a n/a -11K n/a -7K -2K -84K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-9K n/a -333K -10K n/a n/a n/a -102K 26.74M n/a 37K -11K 67K 30K -2K n/a 1.02M -2.6M
Financial Cash Flow
-9K -275K 74.58M 22K -11K -55K 49K -87K 26.74M n/a 37K -11K 72.81M 30K -2K -11.57M 135.87M 100.75M
Net Cash Flow
-4.96M 5.79M -23.08M 24.82M -13.01M -4.04M 838K 7.89M -13.57M -555K -16.38M -6.61M 31.92M 8.99M -26.25M -59.84M 78.18M 13.2M
Free Cash Flow
-10.01M -13.1M -44.75M 22M -12.31M -20.95M -7.2M -24.64M -20.89M -26.91M -19.22M -7.97M -19.85M -21.13M -17.27M -10.66M -12.27M -12.23M